Factors Influencing Therapeutic Non-Adherence Behavior Among Patients with Type 2 Diabetes in Two Public Hospitals in the Gambia: A Cross-Sectional Study

References

• Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of Type 2 Diabetes – global Burden of Disease and Forecasted Trends. J Epidemiol Glob Health. 2019;10(1):107. doi:10.2991/jegh.k.191028.001
   Web of Science ®Google Scholar
• World Health Organization. WHO- Diabetes country profiles. 2023 Available from: https://www.who.int/teams/noncommunicable-diseases/surveillance/data/diabetes-profiles. Accessed April 27, 2023.
   Google Scholar
• World Health Organization. Africa region tops world in undiagnosed diabetes: WHO analysis. Available from: https://www.afro.who.int/news/african-region-tops-world-undiagnosed-diabetes-who-analysis. Accessed November 14, 2023.
   Google Scholar
• Zimmermann M, Bunn C, Namadingo H, Gray CM, Lwanda J. Experiences of type 2 diabetes in sub-Saharan Africa: a scoping review. Glob Health Res Policy. 2018;3(1):25. doi:10.1186/s41256-018-0082-y
   PubMedGoogle Scholar
• Alatawi YM, Kavookjian J, Ekong G, Alrayees MM. The association between health beliefs and medication adherence among patients with type 2 diabetes. Res Social Admin Pharm. 2016;12(6):914–925. doi:10.1016/j.sapharm.2015.11.006
   PubMed Web of Science ®Google Scholar
• Hailu FB, Moen A, Hjortdahl P. Diabetes Self-Management Education (DSME) – effect on Knowledge, Self-Care Behavior, and Self-Efficacy Among Type 2 Diabetes Patients in Ethiopia: a Controlled Clinical Trial</p>. Diabetes Metab Syndr Obes. 2019;12:2489–2499. doi:10.2147/DMSO.S223123
   PubMed Web of Science ®Google Scholar
• Polonsky W, Henry R. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence. 2016;10:1299–1307. doi:10.2147/PPA.S106821
   PubMed Web of Science ®Google Scholar
• Marcum ZA, Sevick MA, Handler SM. Medication Nonadherence: a diagnosable and treatable medical condition. J Am Med Assoc. 2013;309(20):2105–2106. doi:10.1001/jama.2013.4638
   PubMed Web of Science ®Google Scholar
• Aminde LN, Tindong M, Ngwasiri CA, et al. Adherence to antidiabetic medication and factors associated with non-adherence among patients with type-2 diabetes mellitus in two regional hospitals in Cameroon. BMC Endocr Disord. 2019;19(1):35. doi:10.1186/s12902-019-0360-9
   PubMed Web of Science ®Google Scholar
• Mongkhon P, Kongkaew C. Medication Non-Adherence Identified at Home: a Systematic Review and Meta-analysis. Qual Prim Care. 2017;25(2):73–80.
   Google Scholar
• Xu N, Xie S, Chen Y, Li J, Sun L. Factors influencing medication non-adherence among Chinese older adults with diabetes mellitus. Int J Environ Res Public Health. 2020;17(17):6012. doi:10.3390/ijerph17176012
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation. People Living with Diabetes, IDF Diabetes Atlas; 2019.
   Google Scholar
• Ministry of Health. National multi-sectoral strategy and costed action plan for non-communicable disease prevention and control in The Gambia. Available from: https://www.afro.who.int/sites/default/files/2022-07/National%20Multi-sectoral%20Strategy%20and%20Costed%20Action%20Plan%20for%20NCD%20prevention%20and%20control%20-Gambia%202022-27.pdf. Accessed February 10, 2024.
   Google Scholar
• Ministry of Health. Annual service statistics report prepared by health management information system unit at the directorate of planning and information. Available from: https://www.afro.who.int/sites/default/files/2022-07/Final%20Service%20Statistic%20Report%2C%202021.pdf. Accessed June 26, 2024.
   Google Scholar
• Gambia Demographic and Health Survey. The Gambia demographic and health survey 2019-20; 2019.
   Google Scholar
• Health management information system. health service statistics report; 2019.
   Google Scholar
• Azharuddin M, Adil M, Sharma M, Gyawali B. A systematic review and meta‐analysis of non‐adherence to anti‐diabetic medication: evidence from low‐ and middle‐income countries. Int J Clin Pract. 2021;75(11). doi:10.1111/ijcp.14717
   PubMed Web of Science ®Google Scholar
• Cochran WG. Sampling Techniques. John Wiley & Sons; 1977.
   Google Scholar
• Araya EM, Gebrezgabiher HA, Tekulu GH, et al. Medication Non-Adherence and Associated Factors Among Diabetic Patients Visiting General Hospitals in the Eastern Zone of Tigrai, Northern Ethiopia</p>. Patient Prefer Adherence. 2020;14:2071–2083. doi:10.2147/PPA.S278148
   PubMed Web of Science ®Google Scholar
• Murwanashyaka J D, Ndagijimana D, Biracyaza A, Sunday E, Umugwaneza M FX. Non-adherence to medication and associated factors among type 2 diabetes patients at Clinique Medicale Fraternite, Rwanda: a cross-sectional study. BMC Endocr Disord. 2022;22(1):219. doi:10.1186/s12902-022-01133-0
   PubMed Web of Science ®Google Scholar
• Rosenstock IM, Strecher VJ, Becker MH. Social Learning Theory and the Health Belief Model. Health Educ Q. 1988;15(2):175–183. doi:10.1177/109019818801500203
   PubMedGoogle Scholar
• Bress AP, Bellows BK, King JB, et al. Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2017;377(8):745–755. doi:10.1056/NEJMsa1616035
   PubMed Web of Science ®Google Scholar
• Berlowitz DR, Foy CG, Kazis LE, et al. Effect of Intensive Blood-Pressure Treatment on Patient-Reported Outcomes. N Engl J Med. 2017;377(8):733–744. doi:10.1056/NEJMoa1611179
   PubMed Web of Science ®Google Scholar
• Morisky DE, Ang A, Krousel‐Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10(5):348–354. doi:10.1111/j.1751-7176.2008.07572.x
   PubMed Web of Science ®Google Scholar
• Chao J, Nau DP, Aikens JE, Taylor SD. The mediating role of health beliefs in the relationship between depressive symptoms and medication adherence in persons with diabetes. Res Social Admin Pharm. 2005;1(4):508–525. doi:10.1016/j.sapharm.2005.09.002
   PubMedGoogle Scholar
• Gutierrez J, Long JA. Reliability and validity of diabetes specific Health Beliefs Model scales in patients with diabetes and serious mental illness. Diabet Res Clin Pract. 2011;92(3):342–347. doi:10.1016/j.diabres.2011.02.018
   PubMed Web of Science ®Google Scholar
• Morisky D Difference between MMAS-4 and MMAS-8. Morisky medication adherence research. Available from: http://www.moriskyscale.com/blog/difference-between-mmas-4-and-mmas-8#/. Accessed February 10, 2024.
   Google Scholar
• Kim J, Combs K, Tillman F. Medication adherence: the elephant in the room. US Pharmacist. 2018;43(1):30–34.
   Web of Science ®Google Scholar
• Kleinsinger F. The Unmet Challenge of Medication Nonadherence. Perm J. 2018;22(3). doi:10.7812/TPP/18-033
   PubMedGoogle Scholar
• Touray TA, Woodall J, Warwick-Booth L. Lived experience of diet-related health education in type 2 diabetes and hypertension comorbidity in The Gambia. Health Promot Int. 2023;38(5). doi:10.1093/heapro/daad125
   PubMed Web of Science ®Google Scholar
• Pascal IG, Ofoedu JN, Uchenna NP, Nkwa AA, Uchamma GUE. Blood Glucose Control and Medication Adherence Among Adult Type 2 Diabetic Nigerians Attending A Primary Care Clinic in Under-resourced Environment of Eastern Nigeria. N Am J Med Sci. 2012;4(7):310–315. doi:10.4103/1947-2714.98590
   PubMedGoogle Scholar
• Koech C, Nguka G, Oloo PAJ. Factors affecting treatment compliance among type 2 diabetes patients on follow-up at moi teaching & referral hospital. J Health Med Nurs. 2019;4(5):1–11.
   Google Scholar
• Rwegerera GM. Adherence to anti-diabetic drugs among patients with Type 2 diabetes mellitus at Muhimbili National Hospital, Dar es Salaam, Tanzania- A cross-sectional study. Pan Afr Med J. 2014;17. doi:10.11604/pamj.2014.17.252.2972
   Google Scholar
• Waari G, Mutai J, Gikunju J. Medication adherence and factors associated with poor adherence among type 2 diabetes mellitus patients on follow-up at Kenyatta National Hospital, Kenya. Pan Afr Med J. 2018;29. doi:10.11604/pamj.2018.29.82.12639
   Google Scholar
• Bagonza J, Rutebemberwa E, Bazeyo W. Adherence to anti diabetic medication among patients with diabetes in eastern Uganda; a cross sectional study. BMC Health Serv Res. 2015;15(1):168. doi:10.1186/s12913-015-0820-5
   PubMed Web of Science ®Google Scholar
• Barner JC. Adherence to Oral Antidiabetic Agents with Pioglitazone and Metformin: comparison of Fixed-Dose Combination Therapy with Monotherapy and Loose-Dose Combination Therapy. Clin Ther. 2011;33(9):1281–1288. doi:10.1016/j.clinthera.2011.07.016
   PubMed Web of Science ®Google Scholar
• Wong MCS, Kong APS, So WY, Jiang JY, Chan JCN, Griffiths SM. Adherence to Oral Hypoglycemic Agents in 26 782 Chinese Patients: a Cohort Study. J Clin Pharmacol. 2011;51(10):1474–1482. doi:10.1177/0091270010382911
   PubMed Web of Science ®Google Scholar
• Elsous A, Radwan M, Al-Sharif H, Abu Mustafa A. Medications Adherence and Associated Factors among Patients with Type 2 Diabetes Mellitus in the Gaza Strip, Palestine. Front Endocrinol. 2017;8:1–9. doi:10.3389/fendo.2017.00100
   PubMed Web of Science ®Google Scholar
• Ağralı H, Akyar İ. Older diabetic patients’ attitudes and beliefs about health and illness. J Clin Nurs. 2014;23(21–22):3077–3086. doi:10.1111/jocn.12540
   PubMed Web of Science ®Google Scholar
• Hogervorst S, Adriaanse MC, Hugtenburg JG, et al. Medication Intake, Perceived Barriers, and Their Correlates Among Adults With Type 1 and Type 2 Diabetes: results From Diabetes MILES – the Netherlands. Front Clin Diab Healthc. 2021:2. doi:10.3389/fcdhc.2021.645609
   Google Scholar
• Dehdari L, Dehdari T. The determinants of anti-diabetic medication adherence based on the experiences of patients with type 2 diabetes. Arch Public Health. 2019;77(1):21. doi:10.1186/s13690-019-0347-z
   PubMedGoogle Scholar
• Siraj J, Abateka T, Kebede O. Patients’ Adherence to Anti-diabetic Medications and Associated Factors in Mizan-Tepi University Teaching Hospital: a Cross-Sectional Study. Inquiry. 2021;58:004695802110674. doi:10.1177/00469580211067477
   Web of Science ®Google Scholar